Research and analysis

Mpox: adherence and barriers to isolation

This rapid review identified and summarised evidence published before 15 August 2022 relating to adherence and barriers to following isolation guidance for mpox (clade II).

• From: UK Health Security Agency
• Published: 23 January 2025

Documents

Mpox: adherence and barriers to following isolation guidance: a rapid review

Ref: GOV-14169

PDF, 622 KB, 16 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This rapid review identified and summarised the evidence relating to adherence and barriers to following isolation guidance for mpox

The rapid review searched for research published up to 15 August 2022 and includes 3 studies reporting on 2 online surveys.

Only studies including the clade II of mpox were considered, as this is the clade circulating in the 2022 global outbreak, including in the UK.

This was rapid review was originally published 2 March 2023 on a page that has since been withdrawn.

Published 23 January 2025